Clinical Trial Update: Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating desferal administration to improve impaired reaction to hypoxia in type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Desferal (Deferoxamine Mesylate)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: UNKNOWN